(Q37240846)

English

Patients With Proneural Glioblastoma May Derive Overall Survival Benefit From the Addition of Bevacizumab to First-Line Radiotherapy and Temozolomide: Retrospective Analysis of the AVAglio Trial

scientific article published on 29 June 2015

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Patients With Proneural Glioblastoma May Derive Overall Survival Benefit From the Addition of Bevacizumab to First-Line Radiotherapy and Temozolomide: Retrospective Analysis of the AVAglio Trial (English)

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Adaptive radiation therapy

0 references

0 references

1 reference

based on heuristic

inferred from title

0 references

1 reference

based on heuristic

inferred from title

glioblastoma proneural subtype

1 reference

based on heuristic

inferred from title

Richard Bourgon

object named as

Richard Bourgon

2

0 references

object named as

Olivier L Chinot

6

0 references

7

object named as

Wolfgang Wick

1 reference

Europe PubMed Central

19 August 2017

PMC publication ID

Timothy F. Cloughesy

5

object named as

Timothy Cloughesy

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

12

object named as

Albert Lai

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

17

object named as

Lauren E Abrey

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

18

object named as

Heidi S Phillips

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Thomas Sandmann

1

object named as

Thomas Sandmann

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

8

object named as

Ryo Nishikawa

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Roger Henriksson

10

object named as

Roger Henriksson

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

11

object named as

Frank Saran

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

13

object named as

Nicola Moore

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

16

object named as

Priti Hegde

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

author name string

Josep Garcia

3

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Congfen Li

4

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Warren Mason

9

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Samir Kharbanda

14

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Franklin Peale

15

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Carlos Bais

19

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

language of work or name

0 references

publication date

29 June 2015

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

number of pages

10

1 reference

based on heuristic

inferred from page(s)

Journal of Clinical Oncology

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

33

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

25

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

2735-2744

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007-2011.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5015426

6 September 2017

Most human non-GCIMP glioblastoma subtypes evolve from a common proneural-like precursor glioma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5015426

6 September 2017

A randomized trial of bevacizumab for newly diagnosed glioblastoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5015426

6 September 2017

The somatic genomic landscape of glioblastoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5015426

6 September 2017

Acquired resistance to anti-VEGF therapy in glioblastoma is associated with a mesenchymal transition

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5015426

6 September 2017

Identifying the mesenchymal molecular subtype of glioblastoma using quantitative volumetric analysis of anatomic magnetic resonance images

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5015426

6 September 2017

Markers of response for the antiangiogenic agent bevacizumab

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5015426

6 September 2017

The definition of primary and secondary glioblastoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5015426

6 September 2017

Systematic evaluation of medium-throughput mRNA abundance platforms

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5015426

6 September 2017

Evidence for sequenced molecular evolution of IDH1 mutant glioblastoma from a distinct cell of origin.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5015426

6 September 2017

mRNA transcript quantification in archival samples using multiplexed, color-coded probes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5015426

6 September 2017

Molecular subclassification of diffuse gliomas: seeing order in the chaos

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5015426

6 September 2017

Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5015426

6 September 2017

Monoclonal antibody specific for IDH1 R132H mutation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5015426

6 September 2017

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5015426

6 September 2017

Glioblastoma in adults

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5015426

6 September 2017

Direct multiplexed measurement of gene expression with color-coded probe pairs

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5015426

6 September 2017

Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5015426

6 September 2017

MGMT gene silencing and benefit from temozolomide in glioblastoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5015426

6 September 2017

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5015426

6 September 2017

Clinical application of antiangiogenic therapy: microvessel density, what it does and doesn't tell us.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5015426

6 September 2017

Bevacizumab in glioblastoma--still much to learn.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5015426

3 September 2018

Bevacizumab plus radiotherapy-temozolomide for newly diagnosed glioblastoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5015426

3 September 2018

Identification and analysis of in vivo VEGF downstream markers link VEGF pathway activity with efficacy of anti-VEGF therapies.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5015426

3 September 2018

Molecular predictors of progression-free and overall survival in patients with newly diagnosed glioblastoma: a prospective translational study of the German Glioma Network

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5015426

3 September 2018

RefPlus: an R package extending the RMA Algorithm.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5015426

3 September 2018

Impact of vascular endothelial growth factor-A expression, thrombospondin-2 expression, and microvessel density on the treatment effect of bevacizumab in metastatic colorectal cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5015426

3 September 2018

Identifiers

10.1200/JCO.2015.61.5005

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37240846&oldid=2156273873"